Resveratrol protects against arsenic trioxide-induced nephrotoxicity by facilitating arsenic metabolism and decreasing oxidative stress (Q42712581)

5 November 2017

title

Resveratrol protects against arsenic trioxide-induced nephrotoxicity by facilitating arsenic metabolism and decreasing oxidative stress (English)

1 reference

5 November 2017

1 reference

Meiling Yu

1 reference

5 November 2017

Jiangdong Xue

1 reference

5 November 2017

Yijing Li

1 reference

5 November 2017

Weiqian Zhang

1 reference

5 November 2017

Dexing Ma

1 reference

5 November 2017

Lian Liu

1 reference

5 November 2017

Zhigang Zhang

1 reference

5 November 2017

publication date

8 March 2013

1 reference

5 November 2017

published in

Archives of Toxicology

1 reference

5 November 2017

1 reference

5 November 2017

1 reference

5 November 2017

page(s)

1025-1035

1 reference

Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Inhibition by methylated organo-arsenicals of the respiratory 2-oxo-acid dehydrogenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Inhibition of Renal Metabolism. Relative effects of arsenate on sodium, phosphate, and glucose transport by the rabbit proximal tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Mouse arsenic (+3 oxidation state) methyltransferase genotype affects metabolism and tissue dosimetry of arsenicals after arsenite administration in drinking water.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Elevated risk of hypertension induced by arsenic exposure in Taiwanese rural residents: possible effects of manganese superoxide dismutase (MnSOD) and 8-oxoguanine DNA glycosylase (OGG1) genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Protective effect of resveratrol against 6-hydroxydopamine-induced impairment of renal p-aminohippurate transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Resveratrol attenuates cisplatin-induced nephrotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Arsenic trioxide - An old drug rediscovered

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Genetic variants associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase show wide variation across multiple populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Resveratrol protects against 4-hydroxynonenal-induced apoptosis by blocking JNK and c-JUN/AP-1 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Glutathione S-transferase pi in an arsenic-resistant Chinese hamster ovary cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Green tea extract alleviates arsenic-induced biochemical toxicity and lipid peroxidation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Protective effect of trans-resveratrol on gentamicin-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Oxidative mechanism of arsenic toxicity and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Evaluation of 8-hydroxydeoxyguanosine, a typical oxidative DNA damage, in human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Finding a target for resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

The cellular metabolism and systemic toxicity of arsenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Arsenic modulates heme oxygenase-1, interleukin-6, and vascular endothelial growth factor expression in endothelial cells: roles of ROS, NF-κB, and MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

History of the development of arsenic derivatives in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Resveratrol attenuates hepatotoxicity of rats exposed to arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-013-1026-4

10.1007/S00204-013-1026-4

21 January 2018

Identifiers

DOI

1 reference

5 November 2017

1 reference